The Antitumor Effect and Mechanism of Total Flavonoids From Coreopsis Tinctoria Nutt (Snow Chrysanthemum) on Lung Cancer Using Network Pharmacology and Molecular Docking.

Coreopsis tinctoria Nutt active components apoptosis lung cancer network pharmacology

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2022
Historique:
received: 20 08 2021
accepted: 11 02 2022
entrez: 30 3 2022
pubmed: 31 3 2022
medline: 31 3 2022
Statut: epublish

Résumé

Coreopsis tinctoria Nutt (C. tinctoria), also known as Snow Chrysanthemum, is rich in polyphenols and flavonoids. It has important pharmacological effects such as lowering blood lipids, regulating blood glucose, and anti-tumor effect. However, its anti-tumor mechanism has not yet been investigated thoroughly. This study aimed to explore the anti-tumor effect of total flavonoids extracted from C. tinctoria (CTFs) on lung cancer and the possible mechanism. The components of CTFs were analyzed using Ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS). The active components of CTFs were screened according to oral bioavailability (OB) and drug-likeness (DL). Totally, 68 components of CTFs were identified and 23 active components were screened. Network pharmacological analysis on the active components identified 288 potential targets associated with lung cancer. After protein-protein interaction (PPI) network topology analysis, 17 key protein targets including Akt1, MAPK1, TP53, Bcl-2, Caspase-3, Bax, GSK3B and CCND1 were screened. The molecular docking results showed that the active components of CTFs had good binding activity with key targets. GO and KEGG analysis of candidate targets found that the main enrichment was in PI3K/Akt-mediated intrinsic apoptotic pathways. Finally, according to the results of network pharmacology, the potential molecular mechanism of CTFs intervention in lung cancer was validated experimentally

Identifiants

pubmed: 35350758
doi: 10.3389/fphar.2022.761785
pii: 761785
pmc: PMC8957955
doi:

Types de publication

Journal Article

Langues

eng

Pagination

761785

Informations de copyright

Copyright © 2022 Wufuer, Yang, Guo, Aximujiang, Zhong, Yunusi and Wu.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Int J Oncol. 2015 Mar;46(3):1149-58
pubmed: 25586525
Cell Physiol Biochem. 2018;48(3):1060-1074
pubmed: 30041165
J Ethnopharmacol. 2018 Oct 5;224:261-272
pubmed: 29870787
Cell Commun Signal. 2019 Oct 16;17(1):127
pubmed: 31619257
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Molecules. 2016 Sep 30;21(10):
pubmed: 27706037
Biomed Res Int. 2020 May 5;2020:1057943
pubmed: 32461960
Biomed Pharmacother. 2020 Jan;121:109604
pubmed: 31733570
Chem Biodivers. 2019 Dec;16(12):e1900514
pubmed: 31609067
Med Sci Monit. 2020 Mar 30;26:e920537
pubmed: 32225128
Nat Prod Res. 2020 Jun;34(12):1772-1776
pubmed: 30499349
Cell Death Dis. 2019 Mar 4;10(3):218
pubmed: 30833546
Med Princ Pract. 2016;25 Suppl 2:41-59
pubmed: 26679767
Cells. 2020 Feb 18;9(2):
pubmed: 32085497
Mol Med Rep. 2018 Sep;18(3):2914-2922
pubmed: 30015852
Molecules. 2019 Aug 08;24(16):
pubmed: 31398899
Mol Biol Rep. 2020 Jun;47(6):4587-4629
pubmed: 32333246
Molecules. 2020 Jul 09;25(14):
pubmed: 32660101
Nature. 2018 Jan 24;553(7689):446-454
pubmed: 29364287
Oxid Med Cell Longev. 2015;2015:983484
pubmed: 25628774
Biol Res. 2019 Feb 23;52(1):7
pubmed: 30797236
Front Pharmacol. 2019 Mar 19;10:266
pubmed: 30941044
Mol Med Rep. 2017 Oct;16(4):4583-4592
pubmed: 28791364
Oncotarget. 2016 Aug 9;7(32):52517-52529
pubmed: 27232756
Lancet. 2017 Jan 21;389(10066):299-311
pubmed: 27574741
Science. 2004 Jul 30;305(5684):626-9
pubmed: 15286356
Oncol Rep. 2018 Jun;39(6):2969-2977
pubmed: 29658603
Medicine (Baltimore). 2016 Sep;95(1 Suppl 1):S20-S25
pubmed: 27611935
Nutrients. 2018 Nov 26;10(12):
pubmed: 30486290
Cancer Sci. 2020 Apr;111(4):1165-1179
pubmed: 31994822
Int J Mol Med. 2020 Jun;45(6):1814-1824
pubmed: 32236577
Anticancer Agents Med Chem. 2019;19(1):38-47
pubmed: 30599111
J Ethnopharmacol. 2021 Jan 10;264:113281
pubmed: 32810624
Tumori. 2009 Jul-Aug;95(4):409-21
pubmed: 19856649

Auteurs

Yilimire Wufuer (Y)

School of Basic Medical Science, Xinjiang Medical University, Urumqi, China.

Xu Yang (X)

Department of Obstetrics and Gynecology, The Fifth Affiliated People's Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Luyuan Guo (L)

School of Basic Medical Science, Xinjiang Medical University, Urumqi, China.

Kasimujing Aximujiang (K)

School of Basic Medical Science, Xinjiang Medical University, Urumqi, China.

Li Zhong (L)

School of Basic Medical Science, Xinjiang Medical University, Urumqi, China.

Kurexi Yunusi (K)

Uygur Medical College, Xinjiang Medical University, Urumqi, China.

Guixia Wu (G)

School of Basic Medical Science, Xinjiang Medical University, Urumqi, China.

Classifications MeSH